Pharmaceutical firm Orion Corporation announced that Mikko Kemppainen has been appointed as general counsel and secretary to ...

EET Orion's collaboration partner Bayer submits application in China for third indication of darolutamide Orion's collaboration ...

ORION CORPORATION PRESS RELEASE 30 DECEMBER 2024 at 14.00 EET Orion and Marinus terminate agreement for ganaxolone in Europe Orion Corporation (“Orion”) and Marinus Pharmaceuticals, Inc. (“Marinus”) ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

has entered into a preclinical research agreement with Orion Corporation, a leading Finnish pharmaceutical company. As part of the agreement, Evariste will use its innovative discovery platform ...

This photo provided by Lotte Wellfood Co. shows a promotional event for Pepero in New York City. (PHOTO NOT FOR SALE) (Yonhap ...

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) announced on December 23, 2024, that it has entered into a Termination and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Marinus Pharmaceuticals has terminated its agreements with Orion Corporation, including collaboration and supply agreements, as part of its strategic review. The termination includes a mutual release ...

Issues with the Orion spacecraft's heat shield on Artemis 1 have delayed the next mission, Artemis 2. So what happened?

LONDON--(BUSINESS WIRE)--Evariste, a TechBio using mathematics and AI to design small molecule therapeutics, has entered into a preclinical research agreement with Orion Corporation, a leading ...